Related Experiment Video
Updated: Aug 11, 2026

09:46
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Multiple sclerosis co-existent with myxedema. An autopsy case report
Journal of the Neurological Sciences
|November 1, 1984
Summary
This case report details a rare co-occurrence of pituitary and thyroid gland atrophy with demyelinating disorders in a patient presenting with neurological and endocrine dysfunction. The study highlights the diagnostic and therapeutic challenges posed by these combined conditions.
Area of Science:
- Neurology
- Endocrinology
- Pathology
Background:
- This study presents a unique case of a 64-year-old woman with a complex interplay of neurological and endocrine symptoms.
- The patient exhibited progressive neurological deficits and signs suggestive of hormonal imbalance, with seasonal symptom exacerbations.
Observation:
- The patient presented with impaired consciousness, vision loss, sensorimotor paresis, hypothermia, bradycardia, and edema.
- Laboratory findings included high cerebrospinal fluid (CSF) protein and low serum thyroxine (T4) and thyroid-stimulating hormone (TSH) levels.
- Postmortem examination revealed significant atrophy of the pituitary and thyroid glands and demyelinating plaques in the central nervous system.
Findings:
- The case demonstrates the co-existence of pituitary and thyroid gland atrophy with multiple demyelinating lesions.
- Treatment with prednisolone and thyroxine showed transient improvement in consciousness and edema.
- The patient ultimately succumbed to pulmonary embolism.
Implications:
- This report is the first to document the simultaneous occurrence of these two distinct pathological conditions.
- Understanding this rare combination is crucial for diagnosing and managing complex neuroendocrine disorders.
- Further research may elucidate the potential pathogenic links between autoimmune processes affecting the pituitary, thyroid, and central nervous system.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

